Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-24 @ 9:56 PM
NCT ID:
NCT03752632
Eligibility Criteria:
Inclusion Criteria:
* Subject is ≥ 22 years old.
* Subject is assessed as having fair or poor vein quality.
* Subject's both arms are suitable for cannulation.
* Subject will not suffer harm from a delay in having an IV established as determined by the treating clinician.
Exclusion Criteria:
* Subject has existing intravenous access.
* Subject has a planned or existing intra-arterial access.
* Subject has broken, infected or irritated skin and/or dermatological conditions, e.g., eczema, psoriasis and/or allergic reactions, on either forearm.
* Subject has an active implantable medical device.
* Subject wears a transdermal drug delivery patch on her/his forearm.
* Subject has an active/suspected deep vein thrombosis or thrombophlebitis, impaired circulation, impaired sensation, active/uncontrolled bleeding, recently radiated tissue, recent fracture, recent injury or surgery resulting in blood loss \> 100 mL, osteoporosis, localized abscess, localized tuberculosis, and/or a chronic wound with potential underlying osteomyelitis.
* Subject has impaired cognition or communication (unable to provide accurate feedback).
* Subject has a history of seizures and/or epilepsy, and/or a recent seizure, possible recent seizure or a history of possible seizures.
* Subject is pregnant and/or breastfeeding at the time of study enrollment.
* Subject has, at the site of or in between Veinplicity electrode application sites, an active/suspected malignancy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
22 Years
Study:
NCT03752632
Study Brief:
Protocol Section:
NCT03752632